MYC and acute myeloid leukemia: Mechanistically, these studies attribute the function of METTL3 in MLL-AF9 AML to be due to the deposition of m6A on known oncogenic targets such as SP1, MYC, MYB, and BCL2 resulting in translation promotion [51–53].